Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bharat Kalra who started this subject	11/1/2000 10:45:02 PM
From: greedsgd_2000	Read Replies (1) of 1298

Calculated limited ABGX trim-offs - precisely what they need. As everyone knows, cash plus ABGX holdings generally have been dipping below CEGE market value at various times. CEGE has too much going for it, to sit still while market in essence values their science at near zero. CEGE s/b headed higher this winter, my guess is in the 50 to 60 trading range. An ideal combination of very strong financial condition combined with some promising developmental/phase 1/2 biotech science. CEGE clearly one of the most undervalued biotechs on Wall Street.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next